Skip to main content

In Vivo Survival of Human Energy-Replete Carrier Erythrocytes

  • Chapter
Erythrocytes as Drug Carriers in Medicine

Abstract

Erythrocytes have been proposed as carriers of encapsulated therapeutic agents. Encapsulation of therapeutic agents within erythrocytes with a normal mean cell life range of 89 to 131 days (normal half-life of 19 to 29 days) should limit the vascular clearance of the administered drug thus reducing the dosage and frequency of therapeutic interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bax, B.E., Bain, M.D., Ward, C.P., Fensom, A.H. and Chalmers, R.A. The entrapment of mannose-terminated glucocerebrosidase (Alglucerase) in human carrier erythrocytes. Biochem. Soc. Trans. 24: 441S (1996a).

    PubMed  CAS  Google Scholar 

  • Bax, B.E., Fairbanks, D.L., Bain, M.D., Simmonds, H.A. and Chalmers, R.A. The entrapment of polyethylene glycol-bound adenosine deaminase (Pegademase) in human carrier erythrocytes. Biochem. Soc. Trans. 24: 442S (1996b).

    PubMed  CAS  Google Scholar 

  • Bax, B.E., Talbot, P.J., Bain, M.D., Parker-Williams, E.J. and Chalmers, R.A. In vivo survival of human carrier erythrocytes. Clin. Sci. 91:1P (1996c).

    Google Scholar 

  • International Committee for Standardization in Haematology. Recommended methods for radioisotope red-cell survival studies. Br. J. Haematol. 45:659–666 (1980).

    Article  Google Scholar 

  • Sprandel, U., Hubbard, A.R. and Chalmers, R.A. Survival of ‘carrier erythrocytes’ in dogs. Clin. Sci. 59: 7P (1980).

    Google Scholar 

  • Sprandel, U., Hubbard, A.R. and Chalmers, R.A. Towards enzyme therapy using carrier erythrocytes. J. Inher. Metab. Dis. 4:99–100 (1981).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bain, M.D., Bax, B.E., Talbot, P.J., Parker-Williams, E.J., Chalmers, R.A. (1997). In Vivo Survival of Human Energy-Replete Carrier Erythrocytes. In: Sprandel, U., Way, J.L. (eds) Erythrocytes as Drug Carriers in Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0044-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0044-9_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0046-3

  • Online ISBN: 978-1-4899-0044-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics